be shortened significantly,” says group leader Lodewyk Wessels from the Netherlands Cancer Institute and Oncode Institute. He was closely involved in the analysis. “This is illustrated by our identification and validation of the combination of the…
organoids. In May 2020, I joined the group of Lodewyk Wessels to work on a collaborative project with Thijn Brummelkamp's lab, where my aim is to employ computational tools to reconstruct a cellular wiring diagram that describes the underlying…
of proteomics data. I joined the group of Lodewyk Wessels in 2020 to work on a collaborative project with the OncoProteomics lab of Connie Jimenez (VUmc) aimed at identifying anti-EGFR therapy response prediction biomarkers and alternative drug…
during erythropoiesis. I joined the group of Lodewyk Wessels in 2018. My current work involves the application of statistical models and machine learning to omics data for biomarker identification and outcome prediction in several cancer types.
of multi-level omics data. I joined the lab of Lodewyk Wessels and Jos Jonkers at January, 2017, and am investigating anti-cancer drug resistance in breast cancer
of Michiel van der Heijden, Marleen Kok, and Lodewyk Wessels as a PhD student. Here, my projects are related to dissecting the influence of chemotherapy on the tumor microenvironment and finding new biomarkers for cancer immunotherapy. For these…
immunology in the groups of Marleen Kok and Lodewyk Wessels. In my work, I use bioinformatic approaches to explore functional changes in tumor microenvironment and transformed cells during tumor progression and in response to therapy.
In October 2021, I joined the groups of Lodewyk Wessels and Jonas Teuwen as a PhD student. My work focuses on developing AI algorithms for predicting immunotherapy response using data from multiple modalities, including histopathology and genomics.
Ewald van Dyk conducted his PhD research in the Lodewyk Wessel lab and is currently working as a postdoc in the Karin de Visser lab, unraveling mechanisms by which tumors affect the immune system. When: Wednesday January 9th, 12.30 AM Where: Delft…
2022, I joined the groups of Myriam Chalabi and Lodewyk Wessels as a PhD student. My work is focused on translational analysis of cancer immunotherapy trials, with a focus on the gastro-intestinal tract. This involves bioinformatics analysis of…
I am in the groups of Emile Voest and Lodewyk Wessels in the fields of bioinformatics and systems biology. I was trained as a medical doctor and biomedical scientist at the Utrecht University/Utrecht Medical Center and the University of California…
(DK) Combination treatment benefit in CRC - Lodewyk Wessels (NL) 14.00 - 16.15 Afternoon session Pre-clinical drug testing in organoids - Nicola Valeri (UK) WGS in research and clinical practice - Edwin Cuppen/Kris Samsom (NL) PLCRC – real CRC…
This website uses cookies to ensure you get the best experience on our website.